Antibacterials
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
40
NCT04105205
First-In-Human Study of Apramycin
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 25, 2019
Completion: Oct 16, 2020
Loading map...